Back to Search Start Over

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.

Authors :
Zhang, Hongxing
Zhou, Yu
Li, Yicheng
Qin, Wanying
Zi, Yunhua
Liu, Yulan
Qiu, Xiaoying
Xu, Hongyuan
Liao, Weijia
Huang, Zhaoquan
Source :
BMC Cancer; 2/18/2020, Vol. 20 Issue 1, p1-9, 9p, 2 Charts, 3 Graphs
Publication Year :
2020

Abstract

<bold>Background: </bold>Microvascular invasion (MVI) is an independent risk factor for poor prognosis in hepatocellular carcinoma (HCC). However, there is still a lack of preoperative markers to predict MVI in HCC. This study intends to explore the potential application value of the gamma-glutamyl transpeptidase (GGT) to lymphocyte count ratio (GLR) in predicting MVI in HCC and provide guidance for clinical diagnosis and treatment.<bold>Methods: </bold>From March 2010 to December 2015, 230 HCC patients who underwent surgical treatment in the Affiliated Hospital of Guilin Medical University were selected. Clinicopathological parameters between the MVI group (n = 115) and the non-MVI group (n = 115) were comparatively analyzed. The GLR was used as the potential risk factor for HCC with MVI, and its optimal cut-off value was estimated by using the receiver operating characteristic (ROC) curve. The Kaplan-Meier method was used to analyze the survival of HCC patients, and univariate and multivariate Cox regression analyses were used to establish independent predictors affecting postoperative HCC patients.<bold>Results: </bold>The GLR levels in the MVI group and non-MVI group were 84.83 ± 61.84 and 38.42 ± 33.52 (p <  0.001), respectively. According to ROC curve analysis, the optimal cut-off value of GLR was 56.0, and the area under the ROC curve (AUC) was 0.781 (95% CI, 0.719-0.833) for the risk prediction of MVI in HCC patients. Multivariate analysis showed that tumor size > 5 cm, HCC combined with MVI and GLR >  56.0 were independent risk factors for poor prognosis in HCC patients. In addition, compared with the non-MVI group, patients in the MVI group had shorter progression-free survival (PFS) and overall survival (OS).<bold>Conclusion: </bold>GLR could be a predictive biomarker of HCC after operation and a potential predictor of HCC combined with MVI. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712407
Volume :
20
Issue :
1
Database :
Complementary Index
Journal :
BMC Cancer
Publication Type :
Academic Journal
Accession number :
141806239
Full Text :
https://doi.org/10.1186/s12885-020-6628-7